HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales
New Weapons Emerge in the Fight Against Deadly Superbugs
This review summarizes available and emerging therapies for carbapenem-resistant Enterobacterales.
New drug combinations offer hope for patients facing deadly superbugs that resist almost all current antibiotics.
Frontiers
Apr 18, 2026
Infectious Disease
Meta-analysis
Meta-analysis finds no mortality difference between CA and CT for drug-resistant P. aeruginosa infections
Which antibiotic works better for dangerous drug-resistant infections?
A meta-analysis of 10 observational studies including 1409 patients with drug-resistant P.
Two powerful new antibiotics show equal survival rates for patients fighting dangerous, drug-resistant infections.
Apr 2, 2026